KELLY MATTHEWS: Open Payments
NPI 1861941619 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,610 in 182 payments from 25 companies in 2025. Trend: 2023 $3,359 · 2024 $2,770 · 2025 $2,610
Food & beverage: $2,610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $362 |
| Madrigal Pharmaceuticals | 7 | $323 |
| Phathom Pharmaceuticals, Inc. | 26 | $232 |
| Lilly USA, LLC | 10 | $225 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 27 | $217 |
| GENZYME CORPORATION | 7 | $192 |
| PFIZER INC. | 23 | $182 |
| Aimmune Therapeutics, Inc. | 13 | $165 |
| Ipsen Biopharmaceuticals, Inc | 8 | $139 |
| Baxter Healthcare | 6 | $104 |
Products named: REZDIFFRA, DUPIXENT, RINVOQ, VOQUEZNA, RELISTOR, ZENPEP, ZEPBOUND, IQIRVO.
Industry payments across AZ — which companies pay providers there.
